REQUEST A DEMO
Total
USD $0.00
Search more companies

Boehringer Ingelheim (Malaysia) Sdn Bhd (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Glass and Glass Product Manufacturing
Full name: Boehringer Ingelheim (Malaysia) Sdn Bhd Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

To manufacture and distribute pharmaceutical,chemical & animal health care products as well as medical diagnostics, medical devices and provide medical diagnostic laboratory services

Headquarters
Suite15-5, Level 15, Wisma Uoa Damansara Ii, No.6, Jalan Changkat Semantan, Damansara Heights
Kuala Lumpur; Federal Territories; Postal Code: 50490

Contact Details: Purchase the Boehringer Ingelheim (Malaysia) Sdn Bhd report to view the information.

Website: http://www.boehringer-ingelheim.com

Basic Information
Outstanding Shares:
Purchase the Boehringer Ingelheim (Malaysia) Sdn Bhd report to view the information.
Registered Capital:
Purchase the Boehringer Ingelheim (Malaysia) Sdn Bhd report to view the information.
Financial Auditors:
Purchase the Boehringer Ingelheim (Malaysia) Sdn Bhd report to view the information.
Incorporation Date:
January 15, 1986
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Boehringer Ingelheim (Malaysia) Sdn Bhd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
21.05%
Total operating revenue
21.05%
Operating profit (EBIT)
16.08%
EBITDA
11.49%
Net Profit (Loss) for the Period
18.52%
Total assets
-12.55%
Total equity
-32.41%
Operating Profit Margin (ROS)
-0.21%
Net Profit Margin
-0.07%
Return on Equity (ROE)
16.82%
Debt to Equity Ratio
1.97%
Quick Ratio
-0.57%
Cash Ratio
-0.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?